Subscribe to Daily Review - your favourite M&A deals update.

MergerLinks Header Logo

Submit Deal

Submit Deal

Cover Image David Q. Anderson
David Q. AndersonAMPERSAND CAPITAL PARTNERS

David Q. Anderson

General Partner at AMPERSAND CAPITAL PARTNERS

Investor

Deal Bio

Total Deals4
Valued Deals2
Total Value£ 916 M
Avg. Deal Size£ 458 M

Market Context

Sort

29 May 2019|Germany|Pharmaceuticals
VIBALOGICS
Ampersand Capital Partners

Target: VIBALOGICS

Bidder: AMPERSAND CAPITAL PARTNERS

2 Service Providers

1 Target | 1 Bidder

2 Dealmakers

1 Target | 1 Bidder

n/a

Value

26 Feb 2020|Australia|Electrical Components
L3harris (applied Kilovolts And Analytical Instrumentation Business)
Adaptas Solutions

Target: L3HARRIS (APPLIED KILOVOLTS AND ANALYTICAL INSTRUMENTATION BUSINESS)

Bidder: ADAPTAS SOLUTIONS

3 Service Providers

2 Bidder | 1 Vendor

3 Dealmakers

2 Bidder | 1 Vendor

n/a

Value

04 Nov 2024|United States|Biotechnology
Nektar Therapeutics (commercial Pegylation Reagent Manufacturing Business In Alabama)
Ampersand Capital Partners

Target: NEKTAR THERAPEUTICS (COMMERCIAL PEGYLATION REAGENT MANUFACTURING BUSINESS IN ALABAMA)

Bidder: AMPERSAND CAPITAL PARTNERS

6 Service Providers

2 Bidder | 4 Vendor

11 Dealmakers

1 Bidder | 10 Vendor

£ 69 M

Value

06 Nov 2024|United States|Biotechnology
Avid Bioservices
Ampersand Capital Partners

Target: AVID BIOSERVICES

Bidder: AMPERSAND CAPITAL PARTNERS

17 Service Providers

6 Target | 11 Bidder

49 Dealmakers

25 Target | 24 Bidder

£ 846 M

Value

Privacy PolicyTerms of ServiceContact UsCookie Preferences

All rights reserved. Copyright © 2025 Datasite